THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL

Old Brompton Road 123 – London – SW7 3RP
VAT: GB849058102
http://www.icr.ac.uk
Complicit EU Projects
Within the Horizon 2020 (2014-2020) framework, THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL has received € 871,914.0 for its participation in a total of 3 project(s) with a total cost of € 14,029,597.
Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
---|---|---|---|---|---|---|---|---|---|---|
2017-11-01 | 765912 | DRIVE | biochemistry · infectious diseases · cell biology · oncology · molecular biology | 2022-04-30 | participant | € 273,287.88 | € 3,890,064 | 2 | 35 | CORDIS ↪ |
2019-12-01 | 860517 | UBIMOTIF | drug discovery · physiology · employment · enzymes | 2024-05-31 | participant | € 303,172.56 | € 4,143,173 | 1 | 11 | CORDIS ↪ |
2018-01-01 | 754923 | COLOSSUS | gender equality · colorectal cancer · mutation · personalized medicine · employment | 2023-06-30 | participant | € 295,455.64 | € 5,996,359 | 1 | 14 | CORDIS ↪ |
THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL did not participate in complicit projects under Horizon Europe (2021-2027).
Within the FP7 (2007-2013) framework, THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL has received € 853,027.0 for its participation in a total of 1 project(s) with a total cost of € 16,679,047.
Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
---|---|---|---|---|---|---|---|---|---|---|
2011-01-01 | 258236 | SYSCOL | DNA · colorectal cancer · mutation · personalized medicine | 2015-12-31 | participant | € 853,027.9 | € 16,679,047 | 1 | 11 | CORDIS ↪ |